Pamine forte side effects, by duration, gender and age (a phase IV clinical study of FDA data)

female:

1. Arthralgia (joint pain)
2. Arthropathy
3. Asthma
4. Back disorder
5. Blood pressure increased
6. Breast cancer recurrent
7. Depression
8. Diarrhoea
9. Drug hypersensitivity
10. Drug ineffective

male:

1. Anxiety
2. Application site erythema (redness of the skin at application site)

0-1:

n/a

2-9:

n/a

10-19:

1. Abdominal pain

20-29:

1. Abdominal pain upper
2. Abdominal pain

30-39:

1. Abdominal pain
2. Abdominal rigidity
3. Anxiety

40-49:

1. Abdominal adhesions (inflammation of abdomen)
2. Abdominal pain
3. Arthralgia (joint pain)
4. Back disorder
5. Blood pressure increased
6. Diarrhoea
7. Drug ineffective
8. Rash

50-59:

1. Neoplasm malignant (cancer tumour)
2. Breast cancer recurrent
3. Depression
4. Injection site haematoma (localized swelling filled with blood at injection site)

60+:

1. Agitation (state of anxiety or nervous excitement)
2. Dizziness
3. Drug hypersensitivity
4. Influenza like illness
5. Injection site irritation
6. Neoplasm malignant (cancer tumour)

< 1 month:

1. Anxiety

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

1. Blast cells present
2. Abdominal rigidity
3. Agitation (state of anxiety or nervous excitement)
4. Application site erythema (redness of the skin at application site)
5. Arthralgia (joint pain)
6. Arthropathy
7. Asthma
8. Back disorder
9. Breast cancer recurrent
10. Depression